The HCPLive MASH & MASLD page is a comprehensive resource for clinical news and insights on metabolic dysfunction-associated steatotic liver disease and steatohepatitis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for fatty liver disease, steatohepatitis, and more.

Latest News

Florian Koutny, MD | Credit: ResearchGate
Poorly Controlled Type 1 Diabetes Associated with MASLD in Children, Adolescents

April 12th 2024

Results showed poorly controlled HbA1C increased the risk of elevated ALT levels in children and adolescents with type 1 diabetes, suggesting an important link to MASLD.

Liver | Credit: Adobe Stock
HBV Viral Load, Surface Antigen Positivity Not Independently Associated with NAFLD

April 10th 2024

Product image of Resmetirom (Rezdiffra) | Credit: Madrigal Pharmaceuticals
Resmetirom (Rezdiffra) Now Available in US Pharmacies, Marks Turning Point in NASH Management

April 9th 2024

HCPLive Hepatology Month in Review: March 2024
Hepatology Month in Review: March 2024

April 2nd 2024

Craig Parker | Credit: Surrozen
SZN-043 Demonstrates Safety, Pharmacodynamic Effect for Cirrhosis in Phase 1a Trial

April 1st 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.